header logo es

IKCC Clinical Trials Database

Clinical trials are research studies that test the idea that a new treatment or other healthcare intervention is better than the existing drug or practice. Keeping track of ongoing clinical trials for kidney cancer in each country can be a difficult task for patient organisations. The IKCC clinical trials database lists the majority of clinical trials available worldwide that are focused on kidney cancer. Information in this database is automatically updated daily and reviewed weekly.

 
Last Updated:

all countries (with available trials)

all
none

Algeria
Argentina
Australia
Austria
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
Cameroon
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
Estonia
Ethiopia
Finland
France
Georgia
Germany
Ghana
Greece
Guatemala
Hong Kong
Hungary
India
Indonesia
Iran, Islamic Republic of
Ireland
Israel
Italy
Japan
Jordan
Korea, Republic of
Latvia
Lebanon
Lithuania
Luxembourg
Macedonia, the Former Yugoslav Republic of
Malawi
Malaysia
Mexico
Moldova, Republic of
Monaco
Montenegro
Netherlands
New Zealand
Norway
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Puerto Rico
Romania
Russian Federation
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Taiwan, Province of China
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Venezuela, Bolivarian Republic of
Viet Nam

all kidney cancer subtypes

all
none

clear cell renal carcinoma
papillary renal cell carcinoma Type 1
papillary renal cell carcinoma Type 2
chromophobe renal cell carcinoma
collecting duct (Bellini) carcinomas
sarcomatoid renal cell carcinoma
translocation renal cell carcinoma
oncocytoma
renal medullary carcinoma
vhl gene mutation
birt-hogg-dubé syndrome
hereditary leiomyomatosis renal cell carcinoma
wilms tumor
unclassified renal cell carcinoma
other



all countries (with available trials)

all
none

Algeria
Argentina
Australia
Austria
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
Cameroon
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
Estonia
Ethiopia
Finland
France
Georgia
Germany
Ghana
Greece
Guatemala
Hong Kong
Hungary
India
Indonesia
Iran, Islamic Republic of
Ireland
Israel
Italy
Japan
Jordan
Korea, Republic of
Latvia
Lebanon
Lithuania
Luxembourg
Macedonia, the Former Yugoslav Republic of
Malawi
Malaysia
Mexico
Moldova, Republic of
Monaco
Montenegro
Netherlands
New Zealand
Norway
Pakistan
Panama
Peru
Philippines
Poland
Portugal
Puerto Rico
Romania
Russian Federation
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Taiwan, Province of China
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Venezuela, Bolivarian Republic of
Viet Nam

all kidney cancer subtypes

all
none

clear cell renal carcinoma
papillary renal cell carcinoma Type 1
papillary renal cell carcinoma Type 2
chromophobe renal cell carcinoma
collecting duct (Bellini) carcinomas
sarcomatoid renal cell carcinoma
translocation renal cell carcinoma
oncocytoma
renal medullary carcinoma
vhl gene mutation
birt-hogg-dubé syndrome
hereditary leiomyomatosis renal cell carcinoma
wilms tumor
unclassified renal cell carcinoma
other

all phases

all
none

phase 1
phase 2
phase 3
phase 4

all types

all
none

Expanded Access
Interventional
Observational
Observational [Patient Registry]